CIK: 0001907884 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $1,691,850 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | NATERA INC | 2,022,098 | $320,098 | 18.9% | $50.46 | +188.7% | COM | 632307104 |
| PCVX | VAXCYTE INC | 2,336,796 | $191,290 | 11.3% | $76.60 | +29.6% | COM | 92243G108 |
| SPY | SPDR S&P 500 ETF TR | 300,000 | $175,824 | 10.4% | — | — | Put | 78462F103 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 5,064,207 | $127,973 | 7.6% | $31.53 | -13.8% | COM NEW | 15117B202 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 8,520,000 | $112,634 | 6.7% | $17.75 | -3.6% | COM | 87164F105 |
| — | DYNAVAX TECHNOLOGIES CORP | 6,560,835 | $83,782 | 5.0% | $12.15 | — | COM NEW | 268158201 |
| CGON | CG ONCOLOGY INC | 2,519,705 | $72,265 | 4.3% | $34.80 | -1.7% | COM | 156944100 |
| COGT | COGENT BIOSCIENCES INC | 9,105,000 | $71,019 | 4.2% | $7.97 | +25.1% | COM | 19240Q201 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 9,085,368 | $68,322 | 4.0% | $6.66 | +14.0% | COM | 09058V103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,326,262 | $63,764 | 3.8% | $16.61 | +30.9% | COM | 92790C104 |
| VERA | VERA THERAPEUTICS INC | 1,457,910 | $61,655 | 3.6% | $13.27 | +233.7% | CL A | 92337R101 |
| WVE | WAVE LIFE SCIENCES LTD | 4,899,497 | $60,607 | 3.6% | $4.64 | +187.7% | SHS | Y95308105 |
| BEAM | BEAM THERAPEUTICS INC | 1,756,158 | $43,553 | 2.6% | $25.75 | -0.9% | COM | 07373V105 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,225,576 | $36,154 | 2.1% | $29.50 | — | ADS | 45258D105 |
| ENGN | ENGENE HOLDINGS INC | 4,994,090 | $33,211 | 2.0% | $7.65 | +1.5% | COM | 29286M105 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,802,750 | $31,404 | 1.9% | $15.29 | +15.6% | COM | 89422G107 |
| LQDA | LIQUIDIA CORPORATION | 2,266,328 | $26,652 | 1.6% | $8.74 | +25.1% | COM NEW | 53635D202 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 4,685,563 | $20,757 | 1.2% | $7.44 | -45.5% | COM CL A | 46333X108 |
| — | 2SEVENTY BIO INC | 5,953,825 | $17,504 | 1.0% | $9.06 | — | COMMON STOCK | 901384107 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,252,738 | $15,258 | 0.9% | $14.37 | 0.0% | COM | 230031106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 390,792 | $15,085 | 0.9% | $16.61 | +162.5% | COM | 74366E102 |
| TYRA | TYRA BIOSCIENCES INC | 530,478 | $7,374 | 0.4% | $14.84 | +22.3% | COM | 90240B106 |
| BNR | BURNING ROCK BIOTECH LTD | 994,883 | $6,715 | 0.4% | $6.40 | — | SPONSORED ADS | 12233L206 |
| — | SUTRO BIOPHARMA INC | 3,641,447 | $6,700 | 0.4% | $3.73 | — | COM | 869367102 |
| — | AMARIN CORP PLC | 12,414,628 | $6,021 | 0.4% | $1.66 | — | SPONS ADR NEW | 023111206 |
| PRQR | PROQR THRAPEUTICS N V | 1,750,000 | $4,638 | 0.3% | $3.18 | 0.0% | SHS EURO | N71542109 |
| RLAY | RELAY THERAPEUTICS INC | 1,000,000 | $4,120 | 0.2% | $5.44 | 0.0% | COM | 75943R102 |
| CRBU | CARIBOU BIOSCIENCES INC | 2,406,147 | $3,826 | 0.2% | $4.17 | -51.8% | COM | 142038108 |
| — | ACELYRIN INC | 847,366 | $2,661 | 0.2% | $7.11 | — | COM | 00445A100 |
| CLYM | CLIMB BIO INC | 547,000 | $985 | 0.1% | $3.62 | 0.0% | COM | 28658R106 |